Alimentary Pharmacology & Therapeutics

Systematic review: managing anaemia in Crohn's disease
pp. 1507-1523(17)
Authors: KULNIGG, S.; GASCHE, C.

Review article: tolevamer, a novel toxin-binding polymer: overview of preclinical pharmacology and physicochemical properties
pp. 1525-1534(10)
Authors: BARKER, R. H.; DAGHER, R.; DAVIDSON, D. M.; MARQUIS, J. K.

Systematic review and meta-analysis:D-Penicillamine vs. placebo/no intervention in patients with primary biliary cirrhosis - Cochrane Hepato-Biliary Group
pp. 1535-1544(10)
Authors: GONG, Y.; KLINGENBERG, S. L.; GLUUD, C.

Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis
pp. 1545-1552(8)
Authors: RAUTIAINEN, H.; FÄRKKILÄ, M.; NEUVONEN, M.; SANE, T.; KARVONEN, A.-L.; NURMI, H.; KÄRKKÄINEN, P.; NEUVONEN, P. J.; BACKMAN, J. T.

Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease
pp. 1553-1561(9)
Authors: NOBILI, V.; MANCO, M.; DEVITO, R.; CIAMPALINI, P.; PIEMONTE, F.; MARCELLINI, M.

Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C
pp. 1563-1573(11)
Authors: GATSELIS, N. K.; GEORGIADOU, S. P.; KOUKOULIS, G. K.; TASSOPOULOS, N.; ZACHOU, K.; LIASKOS, C.; HATZAKIS, A.; DALEKOS, G. N.

Antinuclear antibodies giving the `multiple nuclear dots' or the `rim-like/membranous' patterns: diagnostic accuracy for primary biliary cirrhosis
pp. 1575-1583(9)
Authors: GRANITO, A.; MURATORI, P.; MURATORI, L.; PAPPAS, G.; CASSANI, F.; WORTHINGTON, J.; GUIDI, M.; FERRI, S.; DE MOLO, C.; LENZI, M.; CHAPMAN, R. W.; BIANCHI, F. B.

Use of antisecretory drugs among consumers of non-steroidal anti-inflammatory drugs in the general population
pp. 1585-1592(8)
Authors: REY, E.; ELOLA-OLASO, C. MORENA; RODRÍGUEZ-ARTALEJO, F.; LOCKE, G. R.; DIAZ-RUBIO, M.

Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy
pp. 1593-1601(9)
Authors: MARIE, I.; DUCROTTE, P.; DENIS, P.; HELLOT, M. F.; LEVESQUE, H.

An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube
pp. 1603-1611(9)
Authors: DEVLIN, J. W.; BAKSHI, A.; BUNGAY, K.; OLSEN, K. M.

Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?
pp. 1613-1621(9)
Authors: KERKHOF, M.; BAX, D. A.; MOONS, L. M. G.; VAN VUUREN, A. J.; VAN DEKKEN, H.; STEYERBERG, E. W.; KUIPERS, E. J.; KUSTERS, J. G.; SIERSEMA, P. D.

Determinants of compliance with colonoscopy in patients with adenomatous colon polyps in a veteran population
pp. 1623-1630(8)
Authors: SIDDIQUI, A. A.; PATEL, A.; HUERTA, S.

Results of a prospective randomised multicentre controlled trial comparing a new 2-L ascorbic acid plus polyethylene glycol and electrolyte solution vs. sodium phosphate solution in patients undergoing elective colonoscopy
pp. 1631-1642(12)
Authors: BITOUN, A.; PONCHON, T.; BARTHET, M.; COFFIN, B.; DUGUÉ, C.; HALPHEN, M.

Budesonide treatment is associated with increased bile acid absorption in collagenous colitis
pp. 1643-1649(7)
Authors: BAJOR, A.; KILANDER, A.; GÄLMAN, C.; RUDLING, M.; UNG, K.-A.

Letters to the Editors
pp. 1651-1652(2)
Authors: Santander, C.; Moreno-Otero, R.; Maté, J.

Anorectal manometry and anal fissure treatment: authors' reply
pp. 1652-1652(1)
Authors: Madoff, R. D.; Steele, S. R.